Seal of approval introduced for psoriasis products
The National Psoriasis Foundation has launched a "seal of recognition" for over-the-counter products to treat psoriasis.
Latest
Publix to open pharmacy at cancer center
Publix Super Markets Inc. plans to provide a full-service retail pharmacy at a cancer treatment facility in Tampa, Fla. The Southeastern food and drug chain said Wednesday that it will begin operating the pharmacy at the Moffitt Cancer Center on July 2.
Online pharmacy safety bill endorsed by NACDS
The National Association of Chain Drug Stores has expressed its support for The Online Pharmacy Safety Act, designed to help protect consumers from illicit online drug sellers. The National Association of Chain Drug Stores (NACDS) today expressed support for H.R.
Zelo hair straightening kit debuts at Navarro
Boca Cosmetics Group is launching its Zelo Keratin Hair Straightening Kit and other hair care products in Navarro Discount Pharmacy stores.
Rite Aid enlists partner for 340B program
Rite Aid Corp. has named CaptureRx as its preferred 340B technology vendor and administrator. The drug chain said Tuesday that via CaptureRx it will offer contract pharmacy services to dispense 340B-priced drugs to patients of eligible community health centers and hospitals nationwide.
PTCB kicks off program to work with employers
The Pharmacy Technician Certification Board (PTCB) has launched the Employer Partnership Program, designed for chain, community and health-system pharmacies that want to encourage pharmacy technicians to participate in the PTCB certification program.
Pfizer buys Emergen-C maker Alacer
Pfizer Inc. has acquired Alacer Corp., the maker and distributor of Emergen-C products, the nation’s largest-selling branded vitamin C product line. Financial terms of the deal, announced Monday, weren’t disclosed.
Mylan’s Mauro tabbed as GPhA chairman
Tony Mauro, president of Mylan North America and its Mylan Pharmaceuticals subsidiary, has been elected as chairman of the Generic Pharmaceutical Association (GPhA) board of directors. Mylan said Friday that Mauro’s term as GPhA chairman will last for one year.
Rite Aid closes offering of new senior notes
Rite Aid Corp. has completed the issuance of $481 million in senior unsecured notes due in 2020, the proceeds from which will be used to help refinance debt. The drug chain said Monday that it has closed its offering, announced earlier this month, of 9.25% senior notes due 2020. Along with
Walgreens recognized as health care innovator
Walgreen Co. has been named as one of the health care industry’s most innovative companies by Fast Company magazine.
APhA poll shows pharmacists’ top OTC picks
The American Pharmacists Association (APhA) has released the results of a survey showing the top over-the-counter cold, flu and allergy medicines recommended by pharmacists.
Coalition chides Express Scripts CEO for remarks
Preserve Community Pharmacy Access Now! (PCPAN), a coalition formed last fall to oppose the merger of Express Scripts Inc. and Medco Health Solutions Inc., blasted Express Scripts chief executive officer George Paz for comments that the group said devalued the role of community pharmacists.
Rite Aid goes to one provider for print, digital circulars
Rite Aid Corp. has named a single printer to handle its weekly newspaper circular as well as the digital version. Quad/Graphics Inc.
Rx groups hail Supreme Court ruling on Medi-Cal
The National Association of Chain Drug Stores, American Pharmacists Association (APhA), National Community Pharmacists Association (NCPA) and National Alliance of State Pharmacy Associations (NASPA) applauded a 5-4 decision by the U.S.
Loeffler blasts Express Scripts-Medco deal
The pending $29 billion merger of Express Scripts Inc. and Medco Health Solutions Inc. is “not bad for a couple of middlemen,” National Association of Chain Drug Stores chairman Bob Loeffler said this month during a withering attack at the organization’s Regional Chain Conference.
As opposition mounts, FTC weighs big PBM deal
Express Scripts Inc. and Medco Health Solutions Inc. have provided the Federal Trade Commission with additional data about their planned merger, even as opposition to the deal grows.